<?xml version="1.0" encoding="UTF-8"?>
<xml>
<records>
<record>
  <contributors>
    <authors>
      <author>Sesma, A.</author>
      <author>Pardo, J.</author>
      <author>Cruellas, M.</author>
      <author>Gálvez, E.M.</author>
      <author>Gascón, M.</author>
      <author>Isla, D.</author>
      <author>Martínez-Lostao, L.</author>
      <author>Ocáriz, M.</author>
      <author>Paño, J.R.</author>
      <author>Quílez, E.</author>
      <author>Ramírez, A.</author>
      <author>Torres-Ramón, I.</author>
      <author>Yubero, A.</author>
      <author>Zapata, M.</author>
      <author>Lastra, R.</author>
    </authors>
  </contributors>
  <titles>
    <title>From tumor mutational burden to blood T cell receptor: Looking for the best predictive biomarker in lung cancer treated with immunotherapy</title>
    <secondary-title>Cancers</secondary-title>
  </titles>
  <doi>10.3390/cancers12102974</doi>
  <pages/>
  <volume/>
  <number/>
  <dates>
    <year>2020</year>
    <pub-dates>
      <date>2020</date>
    </pub-dates>
  </dates>
  <abstract/>
</record>

</records>
</xml>